Novo A/S
Latest statistics and disclosures from Novo Holdings A/S's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BN, ASML, CRM, CORT, LNZA, and represent 37.78% of Novo Holdings A/S's stock portfolio.
- Added to shares of these 9 stocks: BN (+$121M), BAM (+$21M), CABO (+$15M), INSP (+$5.5M), BPMC, IOBT, ACLX, FDMT, RCKT.
- Started 2 new stock positions in BN, BAM.
- Reduced shares in these 6 stocks: Brookfield Asset Management (-$21M), VERV (-$9.4M), Cyteir Therapeutics (-$8.5M), GRTX (-$6.6M), Cymabay Therapeutics (-$6.5M), MIRM (-$5.8M).
- Sold out of its positions in Brookfield Asset Management, GRTX, VERV.
- Novo Holdings A/S was a net buyer of stock by $120M.
- Novo Holdings A/S has $1.4B in assets under management (AUM), dropping by 4.56%.
- Central Index Key (CIK): 0001388325
Tip: Access up to 7 years of quarterly data
Positions held by Novo A/S consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 40 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 9.0 | $121M | NEW | 3.9M | 31.27 |
|
| Asml Holding N V N Y Registry Shs (ASML) | 8.6 | $116M | 198k | 588.66 |
|
|
| salesforce (CRM) | 7.9 | $108M | 531k | 202.78 |
|
|
| Corcept Therapeutics Incorporated (CORT) | 6.8 | $92M | 3.4M | 27.25 |
|
|
| Lanzatech Global (LNZA) | 5.5 | $74M | 16M | 4.67 |
|
|
| Cable One (CABO) | 5.4 | $73M | +25% | 118k | 615.64 |
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 4.6 | $62M | 711k | 86.90 |
|
|
| Disc Medicine (IRON) | 3.8 | $51M | 1.1M | 46.98 |
|
|
| Mirum Pharmaceuticals (MIRM) | 3.5 | $47M | -10% | 1.5M | 31.60 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 3.2 | $43M | 501k | 86.74 |
|
|
| Vaxcyte (PCVX) | 3.2 | $43M | 845k | 50.98 |
|
|
| Arcellx Common Stock (ACLX) | 2.9 | $39M | +7% | 1.1M | 35.88 |
|
| Apple (AAPL) | 2.8 | $38M | 222k | 171.21 |
|
|
| BioMarin Pharmaceutical (BMRN) | 2.6 | $35M | 400k | 88.48 |
|
|
| Edgewise Therapeutics (EWTX) | 2.6 | $35M | 6.1M | 5.73 |
|
|
| Seagen | 2.5 | $34M | 160k | 212.15 |
|
|
| Insmed Com Par $.01 (INSM) | 2.5 | $34M | 1.3M | 25.25 |
|
|
| Crinetics Pharmaceuticals In (CRNX) | 2.4 | $33M | 1.1M | 29.74 |
|
|
| Pharvaris N V (PHVS) | 2.1 | $28M | 1.3M | 20.87 |
|
|
| Blueprint Medicines (BPMC) | 1.9 | $26M | +16% | 525k | 50.22 |
|
| Amicus Therapeutics (FOLD) | 1.9 | $26M | 2.1M | 12.16 |
|
|
| Reneo Pharmaceuticals (RPHM) | 1.9 | $25M | 3.3M | 7.61 |
|
|
| Cymabay Therapeutics | 1.7 | $23M | -21% | 1.6M | 14.91 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $21M | 118k | 177.10 |
|
|
| Brookfield Asset Managmt Cl A Lmt Vtg Shs (BAM) | 1.5 | $21M | NEW | 627k | 33.34 |
|
| Rocket Pharmaceuticals (RCKT) | 1.5 | $21M | +8% | 1.0M | 20.49 |
|
| 4d Molecular Therapeutics In (FDMT) | 1.1 | $15M | +20% | 1.2M | 12.73 |
|
| Spruce Biosciences (SPRB) | 1.1 | $15M | 6.7M | 2.26 |
|
|
| Inspire Med Sys (INSP) | 0.9 | $12M | +84% | 60k | 198.44 |
|
| Io Biotech (IOBT) | 0.6 | $8.1M | +75% | 5.7M | 1.41 |
|
| Rallybio Corp (RLYB) | 0.5 | $7.4M | 2.2M | 3.37 |
|
|
| Abcellera Biologics (ABCL) | 0.4 | $5.2M | 1.1M | 4.60 |
|
|
| Silk Road Medical Inc Common (SILK) | 0.4 | $5.0M | 334k | 14.99 |
|
|
| Treace Med Concepts (TMCI) | 0.3 | $4.7M | 360k | 13.11 |
|
|
| Lava Therapeutics Nv SHS (LVTX) | 0.3 | $3.5M | 2.4M | 1.47 |
|
|
| Marqeta Class A Com (MQ) | 0.2 | $2.6M | 442k | 5.98 |
|
|
| Cyteir Therapeutics | 0.1 | $1.9M | -81% | 676k | 2.84 |
|
| Galecto (GLTO) | 0.1 | $1.8M | 2.5M | 0.72 |
|
|
| Kinnate Biopharma (KNTE) | 0.1 | $1.1M | 816k | 1.40 |
|
|
| Spero Therapeutics (SPRO) | 0.0 | $567k | 469k | 1.21 |
|
Past Filings by Novo Holdings A/S
SEC 13F filings are viewable for Novo Holdings A/S going back to 2014
- Novo Holdings A/S 2023 Q3 filed Nov. 14, 2023
- Novo Holdings A/S 2023 Q2 filed Aug. 14, 2023
- Novo Holdings A/S 2023 Q1 filed May 15, 2023
- Novo Holdings A/S 2022 Q4 filed Feb. 14, 2023
- Novo Holdings A/S 2022 Q3 filed Nov. 14, 2022
- Novo Holdings A/S 2022 Q2 filed Aug. 15, 2022
- Novo Holdings A/S 2022 Q1 restated filed May 27, 2022
- Novo Holdings A/S 2022 Q1 filed May 16, 2022
- Novo Holdings A/S 2021 Q4 filed Feb. 14, 2022
- Novo Holdings A/S 2021 Q3 filed Nov. 15, 2021
- Novo Holdings A/S 2021 Q2 filed Aug. 16, 2021
- Novo Holdings A/S 2021 Q1 filed May 17, 2021
- Novo Holdings A/S 2020 Q4 filed Feb. 16, 2021
- Novo Holdings A/S 2020 Q3 filed Nov. 16, 2020
- Novo Holdings A/S 2020 Q2 filed Aug. 14, 2020
- Novo Holdings A/S 2020 Q1 filed May 15, 2020